Open Access

Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells

  • Authors:
    • Lingqin Zhao
    • Huafeng Shou
    • Lu Chen
    • Wen Gao
    • Chenyan Fang
    • Ping Zhang
  • View Affiliations

  • Published online on: April 12, 2019     https://doi.org/10.3892/or.2019.7115
  • Pages: 3209-3218
  • Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Epigenetic modifications are closely related to oncogene activation and tumor suppressor gene inactivation. The aim of this study was to determine the effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells. Cell proliferation, metastasis, invasion and apoptosis were respectively determined using Cell Counting Kit‑8 (CCK‑8), wound healing, Transwell and flow cytometric assays. Methylation levels were determined using methylation specific PCR (MSP). Related‑factor expression was detected by conducting real‑time‑qPCR (RT‑qPCR) and western blotting. The results revealed that cell proliferation was inhibited by ginsenoside Rg3 (0, 25, 50, 100 and 200 µg/ml) in a time‑dependent manner (12, 24 and 48 h). Ginsenoside Rg3 (50, 100 and 200 µg/ml) was selected to treat cells in various experiments. When ovarian cells were treated with ginsenoside Rg3, cell apoptosis was observed to be promoted, while cell metastasis and invasion were inhibited at 48 h. The results of the present study revealed that in the promoter regions of p53, p16 and hMLH1, the methylation levels decreased, while the mRNA and protein levels significantly increased. The activities of DNMTs and mRNA as well as protein levels of DNMT1, DNMT3a and DNMT3b were decreased by Rg3. The data also demonstrated that the mRNA and protein levels of acetyl‑H3 K14/K9 and acetyl‑H4 K12/K5/K16 were increased by Rg3. Hence, ginsenoside Rg3 inhibited ovarian cancer cell viability, migration and invasion as well as promoted cell apoptosis.
View Figures
View References

Related Articles

Journal Cover

June-2019
Volume 41 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao L, Shou H, Chen L, Gao W, Fang C and Zhang P: Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells. Oncol Rep 41: 3209-3218, 2019
APA
Zhao, L., Shou, H., Chen, L., Gao, W., Fang, C., & Zhang, P. (2019). Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells. Oncology Reports, 41, 3209-3218. https://doi.org/10.3892/or.2019.7115
MLA
Zhao, L., Shou, H., Chen, L., Gao, W., Fang, C., Zhang, P."Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells". Oncology Reports 41.6 (2019): 3209-3218.
Chicago
Zhao, L., Shou, H., Chen, L., Gao, W., Fang, C., Zhang, P."Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells". Oncology Reports 41, no. 6 (2019): 3209-3218. https://doi.org/10.3892/or.2019.7115